Humira and Back pain - a phase IV clinical study of FDA data
Summary:
Back pain is found among people who take Humira, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Humira and have Back pain. It is created by eHealthMe based on reports of 647,817 people who have side effects when taking Humira from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
647,817 people reported to have side effects when taking Humira.
Among them, 13,709 people (2.12%) have Back pain.
What is Humira?
Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 650,617 Humira users for its effectiveness, alternative drugs and more.
What is Back pain?
Back pain is found to be associated with 4,592 drugs and 4,387 conditions by eHealthMe.
Number of Humira and Back pain reports submitted per year:

Time on Humira when people have Back pain *:
Gender of people who have Back pain when taking Humira*:
Age of people who have Back pain when taking Humira *:
Common drugs people take besides Humira *:
Common side effects people have besides Back pain *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Humira and have Back pain?
Check whether Back pain is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
Related studies
How severe was Back pain and when was it recovered:
Expand to all the drugs that have ingredients of adalimumab:
- Back pain and drugs with ingredients of adalimumab (11,037 reports)
Alternative drugs to, pros and cons of Humira:
- Humira (650,617 reports)
Common Humira side effects:
- Drug ineffective: 93,489 reports
- Joint pain: 47,464 reports
- Pain: 47,288 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 39,149 reports
- Fatigue (feeling of tiredness): 38,407 reports
- Rashes (redness): 32,791 reports
- Diarrhea: 27,396 reports
Browse all side effects of Humira:
a b c d e f g h i j k l m n o p q r s t u v w x y zBack pain treatments and more:
- Back pain (333,706 reports)
COVID vaccines that are related to Back pain:
- Back pain in Moderna COVID Vaccine
- Back pain in Pfizer BioNTech Covid Vaccine
- Back pain in Johnson and Johnson Covid Vaccine
Common drugs associated with Back pain:
- Prednisone: 14,935 reports
- Humira: 13,709 reports
- Aspirin: 12,662 reports
- Enbrel: 12,148 reports
- Methotrexate: 12,071 reports
- Tylenol: 8,011 reports
- Omeprazole: 7,705 reports
- Gabapentin: 7,599 reports
- Vitamin d: 7,345 reports
- Metformin: 7,326 reports
All the drugs that are associated with Back pain:
- Back pain (4,592 drugs)
Common conditions associated with Back pain:
- Rheumatoid arthritis: 19,879 reports
- Multiple sclerosis: 14,883 reports
- Osteoporosis: 13,864 reports
- Pain: 11,187 reports
- High blood pressure: 10,629 reports
- High blood cholesterol: 10,372 reports
All the conditions that are associated with Back pain:
- Back pain (4,387 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on adalimumab (the active ingredients of Humira) and Humira (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Carvedilol and Milk Thistle drug interaction - 2 seconds ago
- Omeprazole and Tendon Rupture - 5 seconds ago
- Montelukast Sodium and Multiple Drug Overdose - 8 seconds ago
- Valacyclovir and Carbidopa drug interaction - 12 seconds ago
- Lantus and Chronic Thyroiditis - 14 seconds ago
- Ciloxan and Nuplazid drug interaction - 16 seconds ago
- Implanon and Gastroesophageal Reflux Disease - 27 seconds ago
- Robinul and Pneumonia Viral - 29 seconds ago
- Remeron and Albuterol drug interaction - 36 seconds ago
- Meloxicam and Depo-Medrol drug interaction - 36 seconds ago